• U.K.
    • USA
    • GER
    • CHI
    • PT(BR)

Risk Reduction Solutions for
Pharmaceutical, Life Sciences & Healthcare

  • U.K.
    • USA
    • GER
    • CHI
    • PT(BR)
  • Resources
    • FAQs
    • Quality Certificates
    • Studies & Publications
    • Bioquell QuAD Data Portal
    • Safety Data Sheets
  • News & Events
  • About
    • Company
    • Company Locations
    • Distributors
    • Careers
    • Ecolab Life Sciences
  • Pharmaceuticals & Life Sciences
    • Bioquell and COVID-19
    • Our Technology for Life Sciences
    • Why Bioquell Technology?
    • Systems for Life Sciences
    • Rapid Bio Decontamination Service
    • Validation
    • Consumables and Related Accessories
    • Ecolab Life Sciences
  • Healthcare & EMS
    • Bioquell and COVID-19
    • Why Bioquell Technology?
    • Our Technology for Healthcare
    • Bioquell Compared to UV
    • Aerosolised Versus Bioquell’s Hydrogen Peroxide Vapour
    • Systems for Healthcare
    • Services for Healthcare
    • Emergency Medical Services
    • Consumables and Related Accessories
  • Rapid Bio Decontamination Service
    • Bioquell and COVID-19
    • For Life Sciences
    • For Healthcare
    • Business Continuity
    • RBDS Applications
      • Remediation Needs
      • Emergency Response
      • Disaster Recovery Plan
      • Commissioning
      • End of Campaign and Facility Restart
      • Lab and Research Spaces
      • Hospital Related Contamination Events
  • Qube Isolator
  • Contact
notification

Bioquell and COVID-19
Learn more about Bioquell and Ecolabs response, our solutions, the latest news, and key information about the COVID-19 pandemic.

Click here for more information

x
    • Pharmaceuticals & Life Sciences
      • Bioquell and COVID-19
      • Our Technology for Life Sciences
      • Why Bioquell Technology?
      • Systems for Life Sciences
      • Rapid Bio Decontamination Service
      • Validation
      • Consumables and Related Accessories
      • Ecolab Life Sciences
    • Healthcare & EMS
      • Bioquell and COVID-19
      • Why Bioquell Technology?
      • Our Technology for Healthcare
      • Bioquell Compared to UV
      • Aerosolised Versus Bioquell’s Hydrogen Peroxide Vapour
      • Systems for Healthcare
      • Services for Healthcare
      • Emergency Medical Services
      • Consumables and Related Accessories
    • Rapid Bio Decontamination Service
      • Bioquell and COVID-19
      • For Life Sciences
      • For Healthcare
      • Business Continuity
      • RBDS Applications
        • Remediation Needs
        • Emergency Response
        • Disaster Recovery Plan
        • Commissioning
        • End of Campaign and Facility Restart
        • Lab and Research Spaces
        • Hospital Related Contamination Events
    • Qube Isolator
    • Contact

Bioquell welcomes clarification of biocide regulations by HSE

August 2017

Leading Biodecontamination experts Bioquell warmly welcomes the latest publication by the HSE highlighting the timescale for hydrogen peroxide-based biocides to be compliant.

The HSE Biocides e-Bulletin 22 September 2016 is entitled ‘Active Substance Approval Reminder’ and summarises all of the key dates for the evaluation of hydrogen peroxide in Product Types 1, 2, 3, 4, 5 and 6 under the EU Biocides Regulation 528/2012 (EU BPR).

They confirm that hydrogen peroxide will be approved on 1 February 2017 for use in biocidal products placed on the EU market. All affected companies are reminded that they must apply for UK product authorisation by 1 February 2017 in order to keep their biocidal products on the UK market after the active substance approval date, 1 February 2017.

John Chewins, Bioquell’s Director, Scientific & Regulatory Affairs said, “Biocidal products containing this active substance will therefore need to obtain EU BPR authorisation if they are to remain on the market. Bioquell has already made all the appropriate steps to ensure our market leading product will continue to be on the market going forwards, helping our customers eliminate pathogens and control bioburden.”

The HSE Biocides e-Bulletin 22 September 2016 – Active Substance Approval Reminder can be found here https://content.govdelivery.com/accounts/UKHSE/bulletins/165c362

Sales and Technical Support & General Enquiries: +44 (0)1264 835 835

52 Royce Cl, Andover SP10 3TS, UK

enquiries@bioquell.com

  • © Bioquell, An Ecolab Solution 2025 All Rights Reserved
  • Privacy Policy
  • Terms of Use
Download PDF